Surgical salvage in patients with advanced testicular cancer: indications, risks and outcomes
Open Access
- 1 January 2020
- journal article
- review article
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 9 (S1) , S83-S90
Abstract
The purpose of this review is to present a comprehensive and updated review of the literature and summary of the indications, risks and outcomes related to salvage, desperation and late relapse surgery for advanced testicular cancer. After completing a thorough review of the current literature, this review has attempted to provide an overview of the indications for salvage, desperation and late relapse retroperitoneal lymph node dissection (RPLND) followed by a summary of the histopathologic and clinical outcomes regarding each. Recent literature, combined with a significant contribution from historical studies suggest that while testicular cancer is a relatively uncommon malignancy overall, it represents the most common solid organ malignancy for young men. Although a significant number of men are cured with a combination of first-line treatments, the remaining men are a diverse and often challenging cohort who require the benefit of expertise to improve their outcomes. The role of surgical strategies in the salvage, desperation and late relapse settings is unquestionable, although the most important question remains who will benefit. This often requires a multi-disciplinary approach at centers specializing in this disease process in order to recognize who should get surgery, what surgery to do and how to minimize the potential morbidity associated with the operation.Keywords
This publication has 37 references indexed in Scilit:
- Clinical Outcome and Predictors of Survival in Late Relapse of Germ Cell TumorJournal of Clinical Oncology, 2008
- Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcomeBJU International, 2008
- Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumorsCancer, 2006
- Incidence of Late-Relapse Germ Cell Tumor and Outcome to Salvage ChemotherapyJournal of Clinical Oncology, 2005
- Outcome Analysis for Patients With Elevated Serum Tumor Markers at Postchemotherapy Retroperitoneal Lymph Node DissectionJournal of Clinical Oncology, 2005
- Recent Advances in Conventional-Dose Salvage Chemotherapy in Patients with Cisplatin-Resistant or Refractory Testicular Germ Cell TumorsEuropean Urology, 2005
- Cancer incidence patterns among adolescents and young adults in the United StatesCancer Causes & Control, 2005
- LATE RELAPSE OF TESTICULAR GERM CELL NEOPLASMS: A DESCRIPTIVE ANALYSIS OF 122 CASESJournal of Urology, 2005
- Residual Tumor Resection After High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell CancerJournal of Clinical Oncology, 2004
- Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markersCancer, 2003